Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

NCT06682442 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06682442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06682442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Recruiting
Start date
March 18, 2025
Completion date
March 31, 2032
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal cancer, nasopharyngeal cancer stage, nasopharyngeal carcinoma, stage iii nasopharyngeal carcinoma ajcc v8, stage iva nasopharyngeal carcinoma ajcc v8